Company Filing History:
Years Active: 1989
Title: Hirofumi Yuasa: Innovator in Cardiac Treatment
Introduction
Hirofumi Yuasa is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of cardiac health through his innovative research and development.
Latest Patents
Yuasa holds a patent for an agent aimed at the prophylaxis and treatment of cardiac hypertrophy. This novel agent is designed to address heart failure and comprises as an active ingredient a 2-oxo-imidazolidine compound. The formula includes specific groups where R¹ and R² can be lower alkyl groups, R³ is a phenyl-substituted lower alkyl group, and R⁴ can be a hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof. He has 1 patent to his name.
Career Highlights
Hirofumi Yuasa is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in advancing cardiac treatment options. His work has been pivotal in developing therapies that can significantly improve patient outcomes.
Collaborations
Some of his notable coworkers include Masami Kubo and Takashi Ochiai, who have collaborated with him on various projects within the company.
Conclusion
Hirofumi Yuasa's contributions to cardiac health through his innovative patent demonstrate his commitment to improving medical treatments. His work continues to influence the field positively.